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Metabolic syndrome (MetS), characterized by a constellation of disorders such as hyper-
glycemia, insulin resistance, and hypertension, is becoming a major global public health
problem. Fructose consumption has increased dramatically over the past several decades
and with it the incidence of MetS. However, its molecular mechanisms remain to be
explored. In this study, we used male Sprague-Dawley (SD) rats to study the pathological
mechanism of fructose induced MetS. The SD rats were fed a 60% high-fructose diet for
16 weeks to induce MetS. The induction of MetS was confirmed by blood biochemistry
examination. Proteomics were used to investigate the differential hepatic protein expres-
sion patterns between the normal group and the MetS group. Proteomic results revealed
that fructose-induced MetS induced changes in glucose and fatty acid metabolic pathways.
In addition, oxidative stress and endoplasmic reticulum stress-related proteins were
modulated by high-fructose feeding. In summary, our results identify many new targets for
future investigation. Further characterization of these proteins and their involvement in
the link between insulin resistance and metabolic dyslipidemia may bring new insights
into MetS.
Copyright © 2016, Food and Drug Administration, Taiwan. Published by Elsevier Taiwan
LLC. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).ence and Technology, College of Bioresources and Agriculture, National Taiwan University,
10617, Taiwan.
. Hsieh).
s study.
inistration, Taiwan. Published by Elsevier Taiwan LLC. This is an open access article under the CC
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Metabolic syndrome (MetS), which involves obesity, insulin
resistance, hypertension, and hyperlipidemia, is becoming a
major global public health problem [1,2]. The modern lifestyle
of an increased intake of a palatable high-fat diet in associa-
tion with decreased energy expenditure contributes to the
current rising prevalence of MetS [2,3]. Metabolic syndrome is
complex and encompasses several interrelated disturbances
of glucose and lipid homeostasis [4,5]. The major risk factors
for MetS are abdominal obesity, elevated fasting plasma
glucose, atherogenic dyslipidemia (i.e., increased levels of
triacylglyerols, increased levels of low-density lipoprotein,
and decreased levels of high-density lipoprotein), the pres-
ence of prothrombotic and proinflammatory states, and
elevated blood pressure [6]. The most important interacting
features of MetS have been proposed by Grundy [6] as obesity
plus endogenous metabolic susceptibility, which is man-
ifested by insulin resistance and other factors such as genetic
factors, physical inactivity, advancing age, and endocrine
dysfunction.
Fructose, which occurs naturally in honey and sweet fruits,
is produced in crystalline and syrup forms for commercial use.
The most commonly used form, corn syrup, contains
approximately 55% free fructose. Its use as a sweetener in
processed foods and soft drinks has increased by 20e30% over
the past 20 years in the United States, similar to the dramatic
rise in obesity over the same period [7]. The metabolic effects
of fructose and its use by individuals withmetabolic disorders
have attracted much attention over the past two decades.
Fructose has unique metabolic features because it is largely
metabolized by splanchnic organs (i.e., gut and liver cells)
through insulin-independent mechanisms. Fructose is
involved in the progression to MetS through the dysregulation
of many molecular signaling factors [7,8]. Animal model ex-
periments have clearly demonstrated that fructose feeding in
rats causes hypertension and hyperinsulinemia [9], and in
hamsters causes insulin resistance, hypertriglyceridemia,
hepatic very-low-density lipoprotein overproduction, obesity,
and hyperglycemia [10,11].
Proteomics involves integrating several technologies with
the aim of systematically analyzing the complement of pro-
teins expressed in a biological system in response to specific
stimuli and different physiological or pathological conditions.
Examining changes in the proteome offers insights into
cellular and molecular mechanisms that cannot always be
obtained through genomic analysis. The information gap be-
tween the genome and cellular processes can be largely
attributed to post-translational modifications such as phos-
phorylation and glycosylation. These modifications, which
cannot be monitored by genomic analyses alone, modulate
important regulatory processes such as protein turnover,
protein activity, and protein localization within a cell.
In the current study, we employed the electrospray
ionization-tandem mass spectrometry (ESI-MS/MS) prote-
omics approach to identify candidate molecules that link
high-fructose consumption to the pathogenesis of MetS. Our
results showed that high-fructose feeding was associated
with significant alterations in the expression of hepaticenzymes in multiple pathways. In addition to the marked
upregulation of hepatic functions that promote triglyceride
synthesis and very-low-density lipoprotein-triglycerides pro-
duction, high-fructose consumption also resulted in pertur-
bations of antioxidant functions in protein folding.2. Methods
2.1. Establishment of the high-fructose diet-induced
MetS rat model
Male SpragueeDawley (SD) rats weighing 200e250 g were
housed two animals per cage in an air-conditioned room
(22C ± 2C) on a 12 hour light cycle (7:00 AM to 7:00 PM). The
animals were maintained in accordance with the guidelines
established in the Taiwan Government Guide for the Care and
Use of Laboratory Animals. In this study, we used a well-
established rat model in which insulin resistance, hyperten-
sion, and dyslipidemia can be induced by feeding the animals
a high-fructose diet [12,13]. Rats were randomly divided into
two groups: Group I, which was fed the standard Purina chow
(#5001, Purina, St. Louis, MO, USA; consisting of 23% protein,
56% carbohydrate, 4.5% fat, and 6% fiber), and Group II, which
was fed a 60% high-fructose diet plus the supplement of 21%
protein, 5% fat, and 8% fiber. The dietary manipulation lasted
for 16 weeks. Blood pressure was measured every week, total
cholesterol concentrations weremeasured every 2 weeks, and
an oral glucose tolerance test was performed every 4weeks. At
the end of the experiment, blood pressure was measured, and
the rats were decapitated after overnight fasting. Blood sam-
ples were collected in heparinized tubes, and the plasma was
separated by centrifugation and stored at 20C until assayed
for glucose, insulin, triglyceride, cholesterol, and thio-
barbituric acid-reactive substances. The livers were stored in
liquid nitrogen and subjected to two-dimensional (2-D) gel-
based proteomics.
2.2. Tissue harvest
Frozen livers were crushed in liquid nitrogen into a fine
powder. The resulting powder was dissolved in a lysis buffer
[7M urea, 2 M thiourea, 4% w/v 3-[(3-cholamidopropyl)dime-
thylammonio]-1-propanesulfonate (CHAPS), 0.5% Triton X-
100, and 10 mM dithiothreitol (DTT)] containing a cocktail of
protease inhibitors (cOmplete™ Mini, Roche, Mannheim,
Germany) and centrifuged at 4C and 16,000  g for 60 mi-
nutes. The supernatant was used as the tissue protein lysate.
2.3. Two-dimensional gel electrophoresis and protein
labeling
The protein concentration was determined using the PlusOne
2-D Quant Kit (Amersham Biosciences, Piscataway, NJ, USA) in
accordance with the manufacturer's manual. Approximately
150 mg of protein was dissolved in 350 mL of rehydration buffer
(7M urea, 2 M thiourea, 1% w/v CHAPS, 0.5% Triton X-100, 100
mM DTT and 0.2% v/v immobilized pH gradient buffer, pH
3e11, nonlinear; Amersham Biosciences) and applied to an
18 cm, nonlinear pH 3e10 Immobiline DryStrip (Amersham
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protein from the control group and MetS induced group were
labeled with Cy3 and Cy5 dyes, respectively. The reaction was
then quenched with 10mM lysine for 10 minutes. The labeled
Cy3- and Cy5-treated samples were combined with 8 mL of
DeStreak (GE Healthcare, Little Chalfont, Buckinghamshire,
UK) and 4 mL of pH 3-10 ampholytes (GE Healthcare). The so-
lution volume was adjusted to 440 mL with the necessary
volume of rehydration solution. One-dimension isoelectric
focusing (IEF) was performed on a Protean IEF system (BioRad,
Hercules, CA, USA) using the following program:
0 V  12 hours; 50 V  1 hour; 300 V  1 hour; 600 V  1 hour;
1500 V  2 hours; and 2500 V  2 hours. The gradient was
raised from 2500 V to 8000 V within 2 hours, and IEF was
terminated after a total of 54,000 V/hour. Before separating on
sodium dodecyl sulfate polyacrylamide gel electrophoresis
(SDS-PAGE), the focused immobilized pH gradient strips were
equilibrated in an equilibrium buffer (50 mM Tris-Cl, pH 8.8, 6
M urea, 30% v/v glycerol and 2% w/v SDS) containing 1% w/v
DTT for 15 minutes, and then soaked in the same buffer
containing 2.5% w/v iodoacetamide for 15 minutes. The strips
were then placed on a 10% acrylamide: bis-acrylamide (37:1)
SDS-PAGE gel and immobilized with agarose sealing solution
(0.5% w/v agarose, 25 mM Tris, 192 mM glycine, 0.1% w/v SDS,
and a trace of bromophenol blue). The second-dimensional
SDS-PAGE was performed at 25 mA per gel until the bromo-
phenol blue dye front reached the bottom of the gel. The Cy3
gels were scanned at 580 Bp30 with a green laser (532 nm), and
Cy5 gels were scanned at 670 Bp30 with a red laser (633 nm).
Gels utilized for mass spectroscopy (MS) analysis were run
with 500 mg of protein. Plates were separated, and the gels
were fixed overnight in 30% methanol/10% glacial acetic acid
and stained overnight in Sypro Ruby dye (Molecular Probes™,
Thermo Fisher Scientific, Waltham, MA, USA). Differential gel
presentation was created within a custom-written image
processing program (i.e., Interactive Data Language, Remote
Sensing Image) to correct for scanning detector alterations for
the different wavelengths. Large differences in protein con-
tents were observed in some of these studies; therefore, global
corrections were inadequate. For this procedure, a nonscaled
color overlay of the Cy3 and Cy5 images was used to select a
region of interest (ROI) for use in the scaling function. The ROI
was selected based on the area of the gel in which there was
high signal-to-noise difference in Cy3 and Cy5 with minimal
background noise; this optimized the linear least-squares
approach using the scaling function. In general, the ROI rep-
resented <20% of the total image.
2.4. Mass spectrometry
Gel spots of interest were destained three times with 100 mL
25 mM ammonium bicarbonate (NH4HCO3)/50% v/v acetoni-
trile (ACN) for 15 minutes. The solution was then removed
and 100 mL of 100% ACN was added to dehydrate the gel
pieces. Thereafter, 1.6 mL of 20 ng/mL trypsin (Promega,
Fitchburg, WI, USA) in 25 mM NH4HCO3 was added to the gel
pellets and they were maintained at 4C for 40 minutes. An
extra 2 mL of 25 mM NH4HCO3 was added, and the reaction
was incubated overnight at 37C. Finally, 5 mL of 1% tri-
fluoroacetic acid in 50% aqueous ACN was added and gelpieces were sonicated with 7 mL 1% formic acid for 15 mi-
nutes to release the tryptic peptides for the following MS-
based protein identification. The MS/MS analyses were per-
formed using a Q-TOF-2 system (Waters, Milford, MA, USA) to
identify the selected proteins. The tryptic peptides were
separated on a reversed-phase capillary C18 column (20 mm
id  90 mm id) and directed to the electrospray source of the
mass spectrometer. The mass spectrometer was operated in
positive ion mode with a source temperature of 80C and a
cone voltage of 45 V. A voltage of 3.2 kV was applied to the
source capillary. The time-of-flight analyzer was set in the V-
mode. The MS/MS spectra were obtained in the data-
dependent acquisition mode whereby the two multiple-
charged (i.e., þ2 and þ3) peaks with the four most abun-
dant ions were selected for collision-induced dissociation.
The MS/MS spectra were collected for each of these top four
ions. The parent ion was excluded if the same parent ion was
observed within 90 seconds. Collision energies were set to
10 V for the MS scan and 30 V for the MS/MS scan. Mass
spectra were processed using MassLynx 4.0 (Waters) to
export the .pkl files containing MS/MS peak lists. Protein
identification was performed using .pkl files on the online
MASCOT Server (http://www.matrixscience.com). The set-
tings of the MASCOT parameters were (1) digesting enzyme,
trypsin; (2) missed cleavage site, one; (3) variable modifica-
tion, carbamidomethylation (cysteine) and oxidation
(methionine, histidine, and tryptophan); (4) peptide toler-
ance, <300 ppm; and (5) mass values, MHþ and monoisotopic.
Only proteins with Molecular Weight Search scores above the
significance levels were considered to be positively identified.2.5. Functional classification
Sequences of all identified proteins by MS were submitted to
KOGnitor (http://www.ncbi.nlm.nih.gov/COG/grace/kognitor.
html) for eukaryotic orthologous group (KOG) classification
by a customized Perl script. Nearly all identified proteins can
be assigned a KOG number. A KOG number usually belongs to
one category, although some KOG numbers may belong to
more than one category. Thus, when counting the number of
total proteins with functional classifications, the proteins
associated with more than one category were counted more
than once. The protein ratio for each category was calculated
by dividing the number of proteins within a category by the
sum of assigned proteins from all categories.3. Results
3.1. High-fructose diet-induced MetS in a rat model
To assess the efficacy of high-fructose consumption to induce
MetS in the rat model, we analyzed indicators of MetS such as
body weight, blood pressure, and several blood biochemistry
parameters. As shown in Table 1, after consuming a 60% high-
fructose diet supplement for 16 weeks, the SD rats had
significantly higher blood pressure, higher concentrations of
glucose, insulin, triglycerides, and cholesterol, compared with
the rats maintained on the control chow diet.
Table 1e Bodyweight and biochemical parameters in the
control group versus the metabolic syndrome group.
Group Control MetS
(high-fructose diet)
Body weight (g) 540.8 ± 70.6 560.2 ± 100.1
Glucose (mg/dL) 116.0 ± 3.6 127.5 ± 5.0*
Insulin (ng/mL) 0.3 ± 0.13 0.8 ± 0.29*
Triglyceride (mg/dL) 78.1 ± 15.3 271.3 ± 124.9*
Cholesterol (mg/dL) 66.1 ± 11.6 107.6 ± 25.7*
Blood pressure (mmHg) 104.1 ± 3.0 129.2 ± 8.2*
TBARS (nmol
MDA/mg protein)
0.04 ± 0.01 0.08 ± 0.01*
The values are presented as the mean ± the standard deviation
(n ¼ 8).
*Indicates p < 0.05, compared with the control group. Statistical
analysis is based on the two sample t test.
MDA ¼ malondialdehyde; MetS ¼ metabolic syndrome;
TBARS ¼ thiobarbituric acid-reactive substances.
Figure 1 e Two-dimensional difference gel electrophoresis (2D-
(MetS) group (Cy 5) versus the control group (Cy3). Analysis of t
differentially expressed between the MetS and control groups. O
spots are downregulated. Differentially expressed protein spots
trypsin, and analyzed using MALDI-TOF/MS-MS. Several protei
assisted laser desorption/ionization-time-of-flight/mass spectro
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and the high-fructose-fed rats
To gain insight into the molecular mechanism underlying
MetS in the high-fructose-fed rat model, we employed a 2-D
gel electrophoresis-based proteomics assessment to evaluate
the differential protein expression profiles of the liver tissue.
The liver was studied because it is the major metabolic organ
that responds to MetS induction in rats. As shown in Figures 1
and 2, total liver protein extracts were obtained separately
from the control and MetS rats, and 2-D gel electrophoresis
was used to display the hepatic protein expression patterns
and identify differences. After comparing the density of green
and red fluorescence, which indicates every individual protein
expressed in the liver tissue of the control and MetS rats,
respectively, 21 spots were examined. Of these, using the
merged fluorescent color, 10 spots were identified as having a
significant change of expression (p < 0.05) that was larger than
1.5-fold. The proteins with amerged yellow color indicated noDIGE) analysis of the rat liver in the metabolic syndrome
he resulting 2D-DIGE gel images show 10 protein spots are
f these, eight protein spots are upregulated and two protein
were excised from preparative gels, in-gel digested with
ns are represented by spots. MALDI-TOF/MS-MS ¼ Matrix-
scopy-mass spectroscopy.
Figure 2 e Two-dimensional difference gel electrophoresis (2D-DIGE) analysis of the rat liver in MetS group (Cy 3) versus
control group (Cy5). Analysis of the resulting 2D-DIGE gel images showed 10 protein spots are differentially expressed
between the MetS and control groups. Of these, eight protein spots are upregulated and two protein spots are
downregulated. Differentially expressed protein spots were excised from preparative gels, in-gel digested with trypsin, and
analyzed using MALDI-TOF/MS-MS. Several proteins are represented by spots. MALDI-TOF/MS-MS, matrix-assisted laser
desorption/ionization-time-of-flight/mass spectroscopy-mass spectroscopy.
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fructose-fed groups. Green indicated higher protein expres-
sion in the control group, and red indicated higher protein
expression in the MetS groups. Green and red protein spots
were removed from the gels and subjected to ESI-MS/MS
proteomics. As summarized in Table 2, these differentially
expressed proteins, which may be responsive to the patho-
genesis of MetS, fall into five categories, based on their func-
tional properties, which includes (1) carbohydrate
metabolism/synthesis: fructose-1,6-bisphosphatase 1
(FBPase) and the pyruvate dehydrogenase complex compo-
nent E2 (PDC-E2); (2) fatty acid metabolism/synthesis: fatty
acid synthase (FAS) and acyl-coenzyme A synthetase 1
(ACSM1); (3) antioxidants: glutathione S-transferase alpha 3,
peroxiredoxin I; (4) molecular chaperone: 78 kDa glucose-
regulated protein (GRP78); and (5) others: bifunctional ATP-
dependent dihydroxyacetone kinase/FAD-AMP lyase (ribo-
flavin-cyclic-40,50-phosphate-forming), glial fibrillary acidic
protein (GFAP), and Rho GDP-dissociation inhibitor 1(RhoGDI1). Among the proteins, ASCM1 and Rho GDP-
dissociation inhibitor 1 are downregulated by the high-
fructose diet, and the other eight proteins are upregulated.4. Discussion
Metabolic syndrome encompasses carbohydrate and lipid
metabolismdisorders. The present study used a ratmodel fed a
high-fructose diet that reflected the clinical parameters present
in human MetS patients such as abnormal lipid concentration
in plasma coupled with high blood pressure and insulin resis-
tance. Our liver proteome analysis revealed that enzymes
involved in gluconeogenesis such as FBPase, a regulatory
enzyme in gluconeogenesis that is elevated by obesity and di-
etary fat intake, is induced by the high-fructose diet. Fructose-
1,6-bisphosphatase 1 is an important gluconeogenic enzyme
that catalyzes the hydrolysis of fructose 1,6-bisphosphate to
fructose 6-phosphate and phosphate [14]. A potential basis for
Table 2 e The differential expression of liver proteins in rat in the theme group versus the control group.
No. Protein name Protein ID MW (Da) Function Regulation
1 Fatty acid synthase P12785 272,650 Fatty acid biosynthetic process Up
2 78 kDa glucose-regulated protein P06761 72,347 Unfolded protein binding Up
3 Dihydrolipoyllysine-residue
Acetyltransferase component of
pyruvate dehydrogenase complex,
mitochondrial
P08461 67,166 Acetyl-CoA biosynthetic process
from pyruvate, glycolysis
Up
4 Acyl-coenzyme A synthetase,
mitochondrial
Q91VA0 64,760 Fatty acid metabolism Down
5 Bifunctional ATP-dependent
dihydroxyacetone
kinase/FAD-AMP lyase
(riboflavin-cyclic-40,50-phosphate-forming)
Q4KLZ6 59,444 Glycerol metabolic process Up
6 Glial fibrillary acidic protein P47819 49,957 Cell-specific marker Up
7 Fructose-1,6-bisphosphatase 1 P19112 39,609 Cellular response to insulin
stimulus, fructose 6-phosphate
metabolic process, gluconeogenesis
Up
8 Rho GDP-dissociation inhibitor 1 Q5XI73 23,407 GTPase activator activity Down
9 Glutathione S-transferase alpha 3 B0BNI1 23,961 Aromatic amino acid family metabolic
process, transferase activity
Up
10 Peroxiredoxin I Q63716 22,109 Cell redox homeostasis,
oxidation reduction,
response to oxidative stress
Up
ATP ¼ adenosine triphosphate; MW ¼ molecular weight.
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increased fructose catabolismand favor energy storage inhigh-
fructose-fed rats. In addition, PDC-E2, an enzymecomponent of
the multienzyme pyruvate dehydrogenase complex, was
elevated inourMetS induced rats. The pyruvate dehydrogenase
complex is responsible for pyruvatedecarboxylation toproduce
acetyl-CoA, which is the basic building block of fatty acids. It is
reasonable that after high-fructose consumption, the extra
energy influx increases both gluconeogenesis (we observed the
upregulation of FBPase) and lipid synthesis. In accordance with
this idea, the key enzymes for lipid synthesis such as fatty acid
synthase (FAS) were elevated in MetS rats Fatty acid synthase
may have a role in regulating body weight and in the develop-
ment of obesity [15,16]. Expression of the FAS gene and FAS
activity are increased by insulin in cultured human adipocytes,
which suggests that insulin may modulate their function [17].
Moreover, higher levels of FAS mRNA and protein were
observed in insulin-resistant large adipocytes, compared with
small adipocytes in wild-type mice [18,19], which is consistent
with our finding that insulin resistance is coupled with
increased FAS protein. Recent studies have reported that inhi-
bition of FAS in rodents induces profound weight loss and
reduced food intake, suggesting that FAS may be involved in
obesity through regulation of feeding behavior and energy ho-
meostasis [15,20]. In our rat model, the high-fructose diet
significantly increased abdominal fat pad weight and serum
triacylglycerol concentration (78.1 ± 15.3 mg/dL in the control
rats, 271.3± 124.9mg/dL in high-fructose-fed rats). It is possible
that increased FAS expression enhances the synthesis of fatty
acids and the consequent deposition of lipid in adipose tissue,
alongwith fatty acid release into the circulation, as observed in
the MetS rats. We also observed reduced ACSM1 expression in
rats fed a high-fructose diet. Acyl-coenzyme A synthetase 1
belongs toa large familyof enzymes that catalyze theactivation
of fatty acids by coenzyme A to produce acyl-CoA, the first stepin fatty acid metabolism. As previously reported, mice lacking
ACSL1 specifically in adipose tissue have defects in adipose
fatty acid oxidation [21]. It is possible that high-fructose con-
sumption leads to excess fatty acid synthesis by FAS and re-
duces fatty acid metabolism by ACSM1, thus causing
hyperlipidemia in the rat model.
Glucose-regulated protein was discovered as a cellular
protein induced by glucose starvation [22]. It is a member of
the HSP70 protein family that is primarily present in the
endoplasmic reticulum (ER). It functions as a major chap-
erone that is involved in many cellular processes such as
protein folding and assembly, marking misfolded proteins for
proteosomal degradation [23], regulating calcium (Ca2þ) ho-
meostasis, and serving as a sensor for ER stress [24]. Exces-
sive fat storage stimulates ER stress in liver and adipose
tissue, which subsequently activates inositol-requiring
enzyme 1 (IRE-1) and the downstream kinase, c-Jun NH2
-terminal kinase (JNK), through the ER stress signaling
pathway. Active JNK can phosphorylate the insulin receptor
substrate (IRS)-1 on Ser307, thus inhibiting tyrosine phos-
phorylation of IRS-1 and the downstream insulin signaling
pathway, thereby resulting in insulin resistance [25]. Our
result showed increased GRP78 in the MetS rat, which cor-
relates with insulin resistance, was consistent with the
findings of other research groups.
In this study, we have identified two antioxidant proteins,
glutathione S-transferase and peroxiredoxins, that were up-
regulated with the high-fructose diet. Some reports have
mentioned the effects of antioxidants as being protective
against oxidative stress. Evidence is fast growing that oxida-
tive stress is important not only for normal cell physiology but
also for many pathological processes such as atherosclerosis,
neurodegenerative diseases, and cancer [26e28]. Reactive
oxygen species (ROS) participate in carcinogenesis at all stages
such as initiation, promotion, and progression. Nevertheless,
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ferases during diabetes are inconclusive. Both increased and
decreased hepatic expression of glutathione S-transferases
have been reported in vitro and in vivo. A similar situation
exists for peroxiredoxins, a family of antioxidative proteins.
Peroxiredoxins are capable of protecting cells from ROS
toxicity and regulating signal transduction pathways that in-
fluence cell growth and apoptosis [26]. In vitro, the peroxir-
edoxin genes IeIV are overexpressedwhen hydrogen peroxide
(H2O2) concentrations in cells are elevated [29]. Bast et al [30]
reported that expression of peroxiredoxin I is up-regulated
in cultured insulinoma cells exposed to various stress agents
such as diabetogenic compounds such as alloxan and strep-
tozotocin. Consistent with these data, we have seen that the
high-fructose diet-fed rats exhibited a higher expression of
antioxidant proteins. It is reasonable that development of
MetS may be coupled with ROS production, which in turn in-
duces the antioxidant proteins.
Glial fibrillary acidic protein is an intermediate filament
protein that is expressed by numerous cell types of the
central nervous system such as astrocytes and ependymal
cells. Glial fibrillary acidic protein immunoreactivity was
detected in rat and in human hepatic stellate cells (HSCs),
which exhibit neural/neuroendocrine features. In the rat
liver, GFAP increases in the acute response to injury and
decreases in the chronic response [31]. The activation of
HSCs involves the conversion of quiescent cells into prolif-
erative, contractile, and fibrogenic myofibroblasts. Glial
fibrillary acidic protein expression in the liver is an early
marker of stellate cell activation [32]. Liver inflammation is
the hallmark of early-stage liver fibrosis, and ultimately re-
sults in HSC activation and extracellular matrix deposition
[33]. We did not study tissue histology; however, it is possible
that hyperlipidemia induced by high-fructose diet enhances
lipid deposition in the liver, and activates the inflammationFigure 3 e Proposed signaling transduction pathway, which is
reticulum. The up arrows indicate upregulation and the downsignal transduction pathways that activate stellate cells and
induces the expression of GFAP.
Rho GDP-dissociation inhibitor, an intracellular signaling
effector, is responsive to sequester Rho GTPases in their
inactive GDP-bound states. Rho GTPases have been implicated
in diverse cellular functions and are potential therapeutic
targets in inflammation, cancer, and neurologic diseases
[34,35]. It is possible that a high-fructose diet may down-
regulate the expression of RhoGDI1, and thus activate Rho,
which may contribute to the inflammation state in MetS rats.
Bifunctional ATP-dependent dihydroxyacetone kinase/
FAD-AMP lyase was first discovered in rat liver extracts [36],
and is the only known enzymatic source of the unusual flavin
nucleotide riboflavin 40,50-cyclic phosphate (FMN). Inducible
nitric oxide synthase (iNOS), which is an inflammation
marker, has reduced activity on the loss of the FMN binding
ability. It is possible that high-fructose diet-induced FAD-AMP
lyase provides FMN to facilitate the inflammation-enhancing
function of iNOS. However, the physiological influence of
FAD-AMP lyase on MetS still needs to be further confirmed.5. Conclusions
In summary, our results provide molecular mechanisms that
underlie the abnormal blood biochemistry of MetS. We also
identified many new targets within the liver for future inves-
tigation (Figure 3). Our results show that ER stress, inflam-
mation, and oxidation-related proteins are expressed
coincidently with the onset of insulin resistance and may be
implicated directly in hepatic complications of insulin resis-
tance, insulin signaling attenuation, and/or lipoprotein dys-
regulation. Further characterization of these proteins and
their potential involvement in the link between insulin
resistance and metabolic dyslipidemia is needed.interfered by high fructose induction. ER ¼ endoplasmic
arrows indicate downregulation.
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